RESUMEN
The solid solution Ca9Zn1-xMnxNa(PO4)7 (0 ≤ x ≤ 1.0) was obtained by solid-phase reactions under the control of a reducing atmosphere. It was demonstrated that Mn2+-doped phosphors can be obtained using activated carbon in a closed chamber, which is a simple and robust method. The crystal structure of Ca9Zn1-xMnxNa(PO4)7 corresponds to the non-centrosymmetric ß-Ca3(PO4)2 type (space group R3c), as confirmed by powder X-ray diffraction (PXRD) and optical second-harmonic generation methods. The luminescence spectra in visible area consist of a broad red emission peak centered at 650 nm under 406 nm of excitation. This band is attributed to the 4T1 â 6A1 electron transition of Mn2+ ions in the ß-Ca3(PO4)2-type host. The absence of transitions corresponding to Mn4+ ions confirms the success of the reduction synthesis. The intensity of the Mn2+ emission band in Ca9Zn1-xMnxNa(PO4)7 rising linearly with increasing of x at 0.05 ≤ x ≤ 0.5. However, a negative deviation of the luminescence intensity was observed at x = 0.7. This trend is associated with the beginning of a concentration quenching. At higher x values, the intensity of luminescence continues to increase but at a slower rate. PXRD analysis of the samples with x = 0.2 and x = 0.5 showed that Mn2+ and Zn2+ ions replace calcium in the M5 (octahedral) sites in the ß-Ca3(PO4)2 crystal structure. According to Rietveld refinement, Mn2+ and Zn2+ ions jointly occupy the M5 site, which remains the only one for all manganese atoms within the range of 0.05 ≤ x ≤ 0.5. The deviation of the mean interatomic distance (∆l) was calculated and the strongest bond length asymmetry, ∆l = 0.393 Å, corresponds to x = 1.0. The large average interatomic distances between Mn2+ ions in the neighboring M5 sites are responsible for the lack of concentration quenching of luminescence below x = 0.5.
RESUMEN
ß-Tricalcium phosphate (ß-TCP) is widely used as bone implant material. It has been observed that doping the ß-TCP structure with certain cations can help in combating bacteria and pathogenic microorganisms. Previous literature investigations have focused on tricalcium phosphate structures with silver, copper, zinc, and iron cations. However, there are limited studies available on the biological properties of ß-TCP containing nickel and cobalt ions. In this work, Ca10.5-xNix(PO4)7 and Ca10.5-xCox(PO4)7 solid solutions with the ß-Ca3(PO4)2 structure were synthesized by a high-temperature solid-state reaction. Structural studies revealed the ß-TCP structure becomes saturated at 9.5 mol/% for Co2+ or Ni2+ ions. Beyond this saturation point, Ni2+ and Co2+ ions form impurity phases after complete occupying of the octahedral M5 site. The incorporation of these ions into the ß-TCP crystal structure delays the phase transition to the α-TCP phase and stabilizes the structure as the temperature increases. Biocompatibility tests conducted on adipose tissue-derived mesenchymal stem cells (aMSC) using the (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) (MTT) assay showed that all prepared samples did not exhibit cytotoxic effects. Furthermore, there was no inhibition of cell differentiation into the osteogenic lineage. Antibacterial properties were studied on the C. albicans fungus and on E. coli, E. faecalis, S. aureus, and P. aeruginosa bacteria strains. The Ni- and Co-doped ß-TCP series exhibited varying degrees of bacterial growth inhibition depending on the doping ion concentration and the specific bacteria strain or fungus. The combination of antibacterial activity and cell-friendly properties makes these phosphates promising candidates for anti-infection bone substitute materials.